Pharmaceutical composition comprising N-3-chhloro-4-(3-fluorophenyl)methoxyphenyl6-(52-(methylsulfonyl)ethylaminomethyl-2-furyl-4-quinazolinamine

摘要

The present invention relates to a pharmaceutical composition comprising N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4-quinazolinamine as active pharmaceutical ingredient and a process of preparing such composition.